Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not known to cause stomach ulcers. Peptic ulcers do not appear in its licensed side-effect profile, and clinical trials have not identified them as an associated risk. That said, Mounjaro does affect the digestive system in real ways — and if you already have a history of stomach ulcers, that's worth discussing with a prescriber before starting. These are prescription-only medicines requiring a full clinical assessment; a prescriber weighs your individual history before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1. One of its effects is slowing the rate at which your stomach empties food into the small intestine. That's partly why it reduces appetite so effectively, food sits in the stomach longer, which prolongs the feeling of fullness.
The knock-on effect is that some people experience nausea, belching, acid reflux, indigestion or a heavy feeling in the upper abdomen, particularly in the first few weeks or after a dose increase. These symptoms can feel significant, and it's understandable that someone dealing with them might wonder whether something more serious (like an ulcer) is developing.
The short answer is that delayed gastric emptying does not cause stomach ulcers. Ulcers arise from damage to the stomach lining, most commonly through Helicobacter pylori infection or long-term use of NSAIDs like ibuprofen. Mounjaro's mechanism doesn't involve either of those pathways. The stomach pain some people notice on Mounjaro has a different origin, it's a digestion-slowing effect, not a lining-eroding one.
Still, symptoms overlap enough to cause genuine confusion. If pain is persistent, wakes you at night or feels different from ordinary nausea, it deserves proper clinical attention rather than reassurance from a search engine.
The UK Summary of Product Characteristics (SmPC) for Mounjaro is the definitive reference for what adverse effects have been identified in trials and post-marketing data. Stomach ulcers do not appear in it. The gastrointestinal side effects listed are GI-led: nausea, vomiting, diarrhoea, constipation, abdominal pain, dyspepsia, belching and reflux. These are common and usually mild to moderate, most noticeable in the first couple of weeks or after a dose step up, and tend to settle as the body adjusts.
A separate concern (acute pancreatitis) is flagged in the licensed information and was the subject of an MHRA Drug Safety Update in January 2026. Pancreatitis can cause severe, persistent upper-abdominal pain that radiates to the back, sometimes with vomiting. That's not an ulcer, but it's serious enough to warrant urgent medical attention if it happens. Knowing the difference matters.
For anyone who wants to read the full detail themselves, the NHS medicines page for tirzepatide (NHS.UK's tirzepatide overview) covers the side-effect list in plain language.
Not having ulcers as a known side effect doesn't mean ulcer history is irrelevant. Some people arrive at a Mounjaro consultation already managing peptic ulcer disease, or having had it in the past. This matters for a few reasons.
First, some of the most commonly used painkillers (ibuprofen and other NSAIDs) are themselves ulcer triggers, and it's worth a prescriber knowing if you rely on them. Second, the GI discomfort Mounjaro can produce may be harder to tolerate if the stomach lining is already compromised. Third, distinguishing ulcer flare from treatment side effect is easier when your prescriber knows your full history upfront.
If this is your situation, there's a dedicated page covering taking Mounjaro with a history of stomach ulcers that goes into more detail. The general principle is the same as with most medical decisions: disclose fully, let the clinician assess, and don't assume your history rules you out.
Some people also ask about mouth ulcers specifically. There is a separate question there, you can read about Mounjaro and mouth ulcers if that's what brought you here.
If you're already taking Mounjaro and experiencing persistent or worsening stomach symptoms, the right move is to contact your prescriber, not to stop treatment unilaterally, and not to wait for a routine review if the pain is severe. Mild nausea and bloating in the first week or two after starting or stepping up a dose are expected and well-documented. Sharp, lasting or radiating pain is not.
Signs that need prompt medical review include: pain that spreads from the upper abdomen to the back; vomiting you cannot keep fluids down through; blood in vomit or black/tarry stools; or any symptom that feels qualitatively different from the usual digestive discomfort.
For a broader look at how gastrointestinal side effects on Mounjaro typically present and resolve, that page covers practical management in more detail. And if you're weighing up the full picture of what treatment costs and what's included (clinical review, aftercare, delivery) our cost context page sets it out honestly.
If none of this applies to you yet and you're still at the stage of working out whether Mounjaro is right for your health profile, a prescriber from our clinical team can review your full history. If you're also wondering whether your policy might help with the expense, our page on insurance that covers Mounjaro explains which plans have been known to contribute and what to check with your provider. Check your eligibility with a free consultation, there's no obligation, and the review is done the same day by a real clinician, not a decision tree.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.